Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
OSUR Stock Forecast 2026-2027
$4.15
Current Price
$285.72M
Market Cap
Buy 1
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to OSUR Price Targets
+44.6%
To High Target of $6.00
+14.5%
To Median Target of $4.75
-15.7%
To Low Target of $3.50
OSUR Price Momentum
+3.8%
1 Week Change
+35.6%
1 Month Change
+45.1%
1 Year Change
+71.5%
Year-to-Date Change
-4.2%
From 52W High of $4.33
+99.5%
From 52W Low of $2.08
📊 TOP ANALYST CALLS
Did OSUR Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if OraSure is one of their latest high-conviction picks.
Latest OSUR Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, OSUR has a neutral consensus with a median price target of $4.75 (ranging from $3.50 to $6.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $4.15, the median forecast implies a 14.5% upside. This outlook is supported by 1 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
OSUR Analyst Ratings
1
Buy
1
Hold
0
Sell
OSUR Price Target Range
Low
$3.50
Average
$4.75
High
$6.00
Current: $4.15
Latest OSUR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for OSUR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Nov 12, 2025 | Stephens & Co. | Steven Etoch | Equal-Weight | Maintains | $3.00 |
| May 19, 2025 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| May 8, 2025 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Aug 7, 2024 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Jul 2, 2024 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| May 13, 2024 | JP Morgan | Neutral | Maintains | $N/A | |
| Apr 4, 2024 | Evercore ISI Group | In-Line | Maintains | $N/A | |
| Feb 29, 2024 | JP Morgan | Neutral | Maintains | $N/A | |
| Dec 11, 2023 | Citigroup | Buy | Maintains | $N/A | |
| Nov 8, 2023 | JP Morgan | Neutral | Maintains | $N/A | |
| Jul 17, 2023 | Stephens & Co. | Equal-Weight | Maintains | $N/A | |
| May 11, 2022 | Citigroup | Buy | Maintains | $N/A | |
| Feb 24, 2022 | Citigroup | Buy | Maintains | $N/A | |
| Sep 22, 2021 | Raymond James | Market Perform | Downgrade | $N/A | |
| Aug 4, 2021 | Raymond James | Outperform | Maintains | $N/A | |
| Jun 28, 2021 | Raymond James | Outperform | Maintains | $N/A | |
| May 6, 2021 | Raymond James | Outperform | Maintains | $N/A | |
| Aug 21, 2020 | Evercore ISI Group | Outperform | Initiates | $N/A | |
| Aug 10, 2020 | JP Morgan | Neutral | Initiates | $N/A | |
| Aug 10, 2020 | Citigroup | Buy | Initiates | $N/A |
Orasure Technologies Inc. (OSUR) Competitors
The following stocks are similar to OraSure based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Orasure Technologies Inc. (OSUR) Financial Data
Orasure Technologies Inc. has a market capitalization of $285.72M with a P/E ratio of 19.9x. The company generates $113.02M in trailing twelve-month revenue with a -66.4% profit margin.
Revenue growth is -6.7% quarter-over-quarter, while maintaining an operating margin of -78.4% and return on equity of -21.2%.
Valuation Metrics
Market Cap
$285.72M
Enterprise Value
$113.84M
P/E Ratio
19.9x
PEG Ratio
0.4x
Price/Sales
2.5x
Growth & Margins
Revenue Growth (YoY)
-6.7%
Gross Margin
+42.3%
Operating Margin
-78.4%
Net Margin
-66.4%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+61.9%
Current Ratio
5.5x
Debt/Equity
4.0x
ROE
-21.2%
ROA
-10.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Orasure Technologies Inc. (OSUR) Business Model
About Orasure Technologies Inc.
What They Do
Develops point-of-care diagnostic testing solutions.
Business Model
Orasure Technologies generates revenue by providing innovative diagnostic tests and specimen collection devices primarily for infectious diseases. Their products are sold to a variety of clients, including hospitals, clinics, and public health organizations, enabling timely medical interventions and supporting disease management.
Additional Information
Headquartered in Bethlehem, Pennsylvania, Orasure is recognized for its contributions to public health, particularly in the growing market for at-home and rapid testing solutions, which are essential in contemporary healthcare systems.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
501
CEO
Ms. Carrie Eglinton Manner
Country
United States
IPO Year
1992
Website
www.orasure.comOrasure Technologies Inc. (OSUR) Latest News & Analysis
Latest News
Quick Summary
OraSure Technologies, Inc. (OSUR) held its Q1 2026 earnings call, providing updates on financial performance and company developments. Further details are available in the transcript.
Why It Matters
OraSure's Q1 2026 earnings call reveals financial performance and strategic insights, impacting stock valuation and investor confidence in future growth prospects.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
OraSure Technologies, Inc. (NASDAQ: OSUR) announced its financial results for Q1 2026, ending March 31. Further details on performance were not specified in the excerpt.
Why It Matters
OraSure Technologies' quarterly financial results can indicate its growth trajectory and market performance, impacting stock value and investor sentiment in the diagnostics sector.
Source: GlobeNewsWire
Market Sentiment:
Neutral
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
1 month ago
Quick Summary
OraSure Technologies, Inc. (NASDAQ: OSUR) will host its Q1 2026 earnings conference call on May 6, 2026, at 5 p.m. ET to discuss financial results and business updates.
Why It Matters
OraSure Technologies' upcoming earnings call may reveal key financial performance and strategic developments, impacting stock valuation and investor sentiment.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
OraSure Technologies has entered a Cooperation Agreement with Altai Capital to seek shareholder approval for declassification at the 2026 Annual Meeting.
Why It Matters
The cooperation with Altai Capital indicates potential governance changes, which could enhance shareholder value and influence stock performance, making it a key development for investors.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Activist investor Altai Capital Management urged OraSure Technologies to consider a sale, suggesting the company could achieve a valuation twice its current share price.
Why It Matters
Altai Capital's call for OraSure to explore a sale may indicate potential for significant share price appreciation, attracting interest from investors looking for value opportunities.
Source: Reuters
Market Sentiment:
Positive
Quick Summary
OraSure Technologies is advancing its transformation strategy with key regulatory and commercial milestones expected in 2026. Altai Capital has rejected settlement proposals and seeks board representation.
Why It Matters
OraSure's ongoing transformation and approaching milestones signal potential growth, while Altai's push for board representation indicates possible volatility, impacting stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About OSUR Stock
What is Orasure Technologies Inc.'s (OSUR) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, Orasure Technologies Inc. (OSUR) has a median price target of $4.75. The highest price target is $6.00 and the lowest is $3.50.
Is OSUR stock a good investment in 2026?
According to current analyst ratings, OSUR has 1 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $4.15. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for OSUR stock?
Wall Street analysts predict OSUR stock could reach $4.75 in the next 12 months. This represents a 14.5% increase from the current price of $4.15. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Orasure Technologies Inc.'s business model?
Orasure Technologies generates revenue by providing innovative diagnostic tests and specimen collection devices primarily for infectious diseases. Their products are sold to a variety of clients, including hospitals, clinics, and public health organizations, enabling timely medical interventions and supporting disease management.
What is the highest forecasted price for OSUR Orasure Technologies Inc.?
The highest price target for OSUR is $6.00 from at , which represents a 44.6% increase from the current price of $4.15.
What is the lowest forecasted price for OSUR Orasure Technologies Inc.?
The lowest price target for OSUR is $3.50 from at , which represents a -15.7% decrease from the current price of $4.15.
What is the overall OSUR consensus from analysts for Orasure Technologies Inc.?
The overall analyst consensus for OSUR is neutral. Out of 2 Wall Street analysts, 1 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $4.75.
How accurate are OSUR stock price projections?
Stock price projections, including those for Orasure Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 9, 2026 4:28 AM UTC